Skip to main content
. 2004 Oct 30;54(6):587–598. doi: 10.1007/s00262-004-0602-0

Fig. 1.

Fig. 1

The immunological consequences of tumor cell infection by NDV. a The tumor vaccine ATV-NDV is produced by coincubation of 107 200-Gy irradiated tumor cells with 32 HU of NDV Ulster for 1 h at 37°C. b After intradermal application of the vaccine, virus replication occurs in situ and leads within 24–48 h in the skin to delayed-type hypersensitivity (DTH) reactivity. This may involve distinct innate (46) and adaptive (13) immune mechanisms as analyzed in vitro.